Campanile, Marco (2024) Mechanism of action of therapeutic peptides: from membranes to intracellular targets. [Tesi di dottorato]

[thumbnail of PhD_Thesis_XXXVII_Cycle_Marco_Campanile.pdf] Documento PDF
PhD_Thesis_XXXVII_Cycle_Marco_Campanile.pdf
Visibile a [TBR] Amministratori dell'archivio

Download (5MB) | Richiedi una copia
Tipologia del documento: Tesi di dottorato
Lingua: English
Titolo: Mechanism of action of therapeutic peptides: from membranes to intracellular targets
Autori:
Autore
Email
Campanile, Marco
marco.campanile@unina.it
Data: 12 Dicembre 2024
Numero di pagine: 182
Istituzione: Università degli Studi di Napoli Federico II
Dipartimento: Scienze Chimiche
Dottorato: Scienze chimiche
Ciclo di dottorato: 37
Coordinatore del Corso di dottorato:
nome
email
Lombardi, Angelina
alombard@unina.it
Tutor:
nome
email
Petraccone, Luigi
[non definito]
Del Vecchio, Pompea
[non definito]
Data: 12 Dicembre 2024
Numero di pagine: 182
Parole chiave: Peptides, nucleic acids, biophysics
Settori scientifico-disciplinari del MIUR: Area 03 - Scienze chimiche > CHIM/02 - Chimica fisica
Informazioni aggiuntive: Appartenente al 37° ciclo di dottorato
Depositato il: 20 Gen 2026 19:19
Ultima modifica: 09 Ago 2026 06:01
URI: https://www.fedoa.unina.it/id/eprint/16523

Abstract

Therapeutic peptides have emerged as promising candidates to combat diseases such as cancer and viral infections. Among them, host defense peptides (HDPs) are evolutionary conserved molecules with anticancer, antimicrobial and antiviral properties. This PhD thesis focuses on non-membranolytic HDPs, particularly LL-III, and their ability to interact with both cellular membranes and intracellular targets. Using biophysical techniques, LL-III was shown to transiently destabilize negatively charged model tumor membranes, enabling its non-disruptive internalization. The peptide was then tested against biologically relevant DNA G-quadruplexes as possible intracellular targets and was found to exhibit a nanomolar affinity despite the lack of common G-quadruplex binding motifs. To establish whether LL-III can also recognize non-canonical RNA structures, a sequence from the SARS-CoV-2 genome, RG1, was selected. The RG1 was shown to adopt a G-triplex conformation rather than the previously assumed G-quadruplex at physiological temperature. Preliminary data indicated that LL-III can successfully recognize RG1 under these conditions, suggesting that this peptide may also hold potential as an antiviral agent. Finally, LL-III’s effects on a model SARS-CoV-2 condensate containing the nucleocapsid protein were assessed, showing that the peptide can alter the shape and dynamics of the viral condensates, with possible implications the viral replication. Comparative studies with other HDPs provided a first glimpse into the role of peptide physicochemical properties in biomolecular condensates modulation. This work underscores the broader therapeutic potential of non-membranolytic HDPs, paving the way for innovative and effective multi-target therapeutic strategies.

Downloads

Downloads per month over past year

Actions (login required)

Modifica documento Modifica documento